MindMed

We will report our Q3 2025 financial results and business updates during a live webcast at 4:30 p.m. EST on November 6, 2025. See press release here for details and to register: https://lnkd.in/g9HzACWS

Living with generalized anxiety disorder (GAD) can be overwhelming, and research is essential to better understand this condition and potential paths forward. MindMed is conducting a clinical research study for adults living with GAD. If you or someone you know is interested in learning more, visit https://lnkd.in/ed_ZKW3z #GeneralizedAnxietyDisorder #ClinicalTrial #MentalHealth #Anxiety

At MindMed, we recognize that mental health is fundamental to overall well-being. This year’s World Mental Health Day theme — “Mental health is a universal human right” — reminds us that access to mental health care, understanding, and compassion should be available to everyone, everywhere. We remain committed to advancing research and developing new approaches that could transform how we understand and address brain health disorders. #WMHD #WorldMentalHealthDay #MentalHealthAwareness #BrainHealth #MindMed  

MDD is one of the most common — and most misunderstood — mental health conditions. This Mental Illness Awareness Week, we’re bringing attention to the impact that depression has on individuals, families, and communities. At MindMed, we’re forging a new era in psychiatry to meet the needs of those living with serious mental illness. #MIAW #DepressionAwareness #MentalHealthMatters #BrainHealthDisorders 

Today is National Depression Screening Day — a reminder that regular assessment of our mental health is just as important as caring for our physical health. Screenings can be the first step toward understanding, support, and healing. At MindMed, we’re committed to advancing science and awareness around serious mental health conditions and standing with everyone impacted by depression. #DepressionScreeningDay #MIAW #MentalHealthAwareness #BrainHealth 

  Today, our CMO Dan Karlin takes the stage at Fierce Biotech Week 2025 in Boston. Panel: Resurgence of Neuroscience Drug Development  Wednesday, October 8 | 4:30 PM ET  Encore Boston Harbor More Info: https://lnkd.in/geRCWjKG    We’re proud to be part of the conversation on the future of biotech and the innovations shaping tomorrow’s treatments. Stay tuned for highlights from the panel.  #FierceBiotechWeek2025 #Biotech #MindMed 

This week, we join NAMI and the broader community in recognizing Mental Illness Awareness Week (Oct 5–11). Mental health touches everyone—and by building community, compassion, and understanding, we can help reduce stigma and support those who are suffering. At MindMed, we’re committed to moving psychiatry forward while standing with the millions of people and families impacted by mental illness. #MIAW #MentalHealth #BuildingCommunity 

Earlier this month, Dr. Jamileh Jemison presented at the 8th Neuropsychiatric Drug Development Summit, where she highlighted results from our Phase 2b study—recently published in JAMA—and provided an overview of our ongoing Phase 3 trials in Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD). She also joined fellow industry peers for an important panel discussion on optimizing clinical trial design for psychedelics.    As Dr. Jemison’s presentation highlighted, by advancing psychedelic research with scientific rigor and transparency, we are forging a new era of psychiatry and unlocking potential solutions for the millions of people living with GAD and MDD.    #Neuropsychiatry #ClinicalTrials  

Don’t miss our CMO, Dan Karlin, at Fierce Biotech Week 2025. He’ll be joining a panel on Resurgence of Neuroscience Drug Development, bringing MindMed’s science and perspective to the conversation as we forge together as an industry to advance innovation in biotech.    Wednesday, October 8 | 4:30 - 5:15 ET Encore Boston Harbor | Picasso 4 & 5   Learn more: https://lnkd.in/geRCWjKG #FierceBiotechWeek2025 #BiotechInnovation #ClinicalInnovation #InsideMindMed #Leadership

Did you know that nearly half of patients living with severe generalized anxiety disorder (GAD) report experiencing suicidal thoughts almost every day? In fact, the likelihood of suicidal ideation (SI) increases as anxiety symptoms become more severe. Yesterday at Psych Congress 2025, Erin Ferries Ph.D., MPH, shared these new study findings and more, reinforcing the critical need for routine suicide risk screening and timely intervention for those living with anxiety disorders.     September is Suicide Prevention Awareness month and a reminder that mental health care is not just about day-to-day struggles; it is, for some, a matter of life or death. Learn more: https://bit.ly/4gtJ0xT